Universidade Federal da Sao Paulo

Site:	Universidade Federal da Sao Paulo
Address:
City:	Sao Paulo
State:
Zip:
Country:	Brazil

Phase	Trial	Trial Status [asc]	Site Status	Drug	NCT#
3	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)	Completed	Closed	Nilotinib or Imatinib	NCT00785785